Titan Pharmaceuticals Inc (TTNP) — Capital Reinvestment Ratio
Latest as of June 2016:
0.00x
Titan Pharmaceuticals Inc (TTNP) has a Capital Reinvestment Ratio of 0.00x as of June 2016, meaning it reinvests 0% of its operating cash flow ($13.51 Million) in capital expenditures ($9.00K). See Titan Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$13.51 Million
USD
Capital Expenditures
$9.00K
USD
Data as of
Jun 2016
Most recent filing
Titan Pharmaceuticals Inc Capital Reinvestment Ratio (1997–2016)
This chart tracks Titan Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Titan Pharmaceuticals Inc (1997–2016)
Year-by-year Capital Reinvestment Ratio for Titan Pharmaceuticals Inc from 1997 to 2016. For live market cap and broader valuation context, see TTNP company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.03x | $6.29 Million | $171.00K | ▼ -95.7% |
| 2012 | 0.63x | $1.83 Million | $1.15 Million | ▲ +4377.3% |
| 1997 | 0.01x | $7.10 Million | $100.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow